Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
19.4M
-
Shares change
-
-1.39M
-
Total reported value, excl. options
-
$96.1M
-
Value change
-
-$30.4M
-
Put/Call ratio
-
0.5
-
Number of buys
-
50
-
Number of sells
-
-17
-
Price
-
$4.95
Significant Holders of OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) as of Q2 2016
81 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - COMMON STOCK as of Q2 2016.
OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.4M shares
of 159M outstanding shares and own 12.18% of the company stock.
Largest 10 shareholders include FMR LLC (3.71M shares), JENNISON ASSOCIATES LLC (2.97M shares), Versant Venture Management, LLC (2.22M shares), SV Life Sciences Advisers, LLC (1.93M shares), FEDERATED INVESTORS INC /PA/ (1.4M shares), Polaris Venture Management Co. V, L.L.C. (999K shares), WELLINGTON MANAGEMENT GROUP LLP (961K shares), BlackRock Fund Advisors (776K shares), VANGUARD GROUP INC (479K shares), and PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. (353K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.